Innovate Corp. 8-K Filing
Ticker: VATE · Form: 8-K · Filed: Mar 31, 2026 · CIK: 0001006837
| Field | Detail |
|---|---|
| Company | Innovate Corp. (VATE) |
| Form Type | 8-K |
| Filed Date | Mar 31, 2026 |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Innovate Corp. (ticker: VATE) to the SEC on Mar 31, 2026.
What are the key financial figures in this filing?
Key dollar amounts include: $0.001 (ich registered Common Stock, par value $0.001 per share VATE New York Stock Exchange).
How long is this filing?
Innovate Corp.'s 8-K filing is 2 pages with approximately 513 words. Estimated reading time is 2 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 513 words · 2 min read · ~2 pages · Grade level 10 · Accepted 2026-03-31 09:00:33
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share VATE New York Stock Exchange
Filing Documents
- hchc-20260331.htm (8-K) — 33KB
- a202603318-kxexhibit991.htm (EX-99.1) — 18KB
- innovateforproxya.jpg (GRAPHIC) — 17KB
- 0001006837-26-000019.txt ( ) — 242KB
- hchc-20260331.xsd (EX-101.SCH) — 3KB
- hchc-20260331_def.xml (EX-101.DEF) — 17KB
- hchc-20260331_lab.xml (EX-101.LAB) — 30KB
- hchc-20260331_pre.xml (EX-101.PRE) — 17KB
- hchc-20260331_htm.xml (XML) — 4KB
01 Other Events
Item 8.01 Other Events. On March 31, 2026, the Company issued a press release titled "MediBeacon Transdermal GFR Monitor and Reusable Sensor Receive CE Mark Under European Medical Device Regulation". A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K. Exhibit 99.1 shall not be deemed filed for purposes of Section 18 of the Exchange Act, nor shall it be deemed incorporated by reference in any filing under the Securities Act, except as shall be expressly set forth by specific reference in a filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release dated March 31, 2026, titled "MediBeacon Transdermal GFR Monitor and Reusable Sensor Receive CE Mark Under European Medical Device Regulation" 104 Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: March 31, 2026 INNOVATE Corp. (Registrant) By: /s/ Michael J. Sena Name: Michael J. Sena Title: Chief Financial Officer